Korro Bio, Inc. (KRRO)
(Real Time Quote from BATS)
$48.95 USD
-0.20 (-0.41%)
Updated Jul 15, 2024 03:26 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
KRRO 48.95 -0.20(-0.41%)
Will KRRO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for KRRO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KRRO
Wall Street Analysts Believe Korro Bio, Inc. (KRRO) Could Rally 86.94%: Here's is How to Trade
Best Momentum Stocks to Buy for February 16th
KRRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for February 16th
Does Korro Bio, Inc. (KRRO) Have the Potential to Rally 59.66% as Wall Street Analysts Expect?
Other News for KRRO
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023
Korro Bio’s Chief Scientific Officer Announces Resignation
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), AbbVie (ABBV) and Emergent Biosolutions (EBS)
option delistings on June 3rd
Korro to Participate in Upcoming June Investor and Scientific Conferences